| Caris Life Sciences, Inc. | 8.26M | US$147M | 5.4% |
| Hinge Health, Inc. | 1.33M | US$110M | 4.1% |
| Glaukos Corporation | 592K | US$82.7M | 3.1% |
| Edgewise Therapeutics, Inc. | 2M | US$81.1M | 3.0% |
| Spyre Therapeutics, Inc. | 879K | US$78.1M | 2.9% |
| Irhythm Holdings, Inc. | 654K | US$77.8M | 2.9% |
| Neogenomics, Inc. | 4.92M | US$71.8M | 2.7% |
| Kodiak Sciences Inc | 1.79M | US$69.6M | 2.6% |
| Xenon Pharmaceuticals Inc. | 1.13M | US$68.3M | 2.5% |
| Monte Rosa Therapeutics, Inc. | 2.45M | US$59.3M | 2.2% |
| Dianthus Therapeutics, Inc. | 595K | US$58M | 2.1% |
| Neurocrine Biosciences, Inc. | 336K | US$56.7M | 2.1% |
| Alphatec Holdings, Inc. | 6.53M | US$56.5M | 2.1% |
| Generate Biomedicines, Inc. | 3.28M | US$55.4M | 2.0% |
| Maravai Lifesciences Holdings, Inc. | 8.7M | US$54.3M | 2.0% |
| Krystal Biotech, Inc. | 129K | US$47.9M | 1.8% |
| Humana Inc. | 115K | US$45.5M | 1.7% |
| Thermo Fisher Scientific Inc | 89,395 | US$44.8M | 1.7% |
| Kymera Therapeutics, Inc. | 378K | US$43.4M | 1.6% |
| Rhythm Pharmaceuticals, Inc. | 381K | US$42.3M | 1.6% |
| Damora Therapeutics, Inc. | 1.62M | US$42.1M | 1.6% |
| Acadia Pharmaceuticals Inc. | 1.65M | US$41.7M | 1.5% |
| Brightspring Health Services, Inc. | 597K | US$41.6M | 1.5% |
| Transmedics Group, Inc. | 610K | US$40.5M | 1.5% |
| Mbx Biosciences, Inc. | 711K | US$39.2M | 1.5% |
| Climb Bio, Inc. | 2.8M | US$36.5M | 1.3% |
| Caredx, Inc. | 1.22M | US$34.8M | 1.3% |
| Maze Therapeutics, Inc. | 1.14M | US$34M | 1.3% |
| Bright Minds Biosciences Inc. | 484K | US$34M | 1.3% |
| Acadia Healthcare Company, Inc. | 1.14M | US$33.7M | 1.2% |
| Nektar Therapeutics | 474K | US$33.1M | 1.2% |
| Corvus Pharmaceuticals, Inc. | 2.13M | US$31.8M | 1.2% |
| Nurix Therapeutics, Inc. | 1.29M | US$31.2M | 1.2% |
| Inspire Medical Systems, Inc. | 678K | US$30.2M | 1.1% |
| Avalo Therapeutics, Inc. | 1.63M | US$30.1M | 1.1% |
| Alamar Biosciences, Inc. | 1.08M | US$29.4M | 1.1% |
| Danaher Corporation | 151K | US$28.7M | 1.1% |
| Intuitive Surgical, Inc. | 70,137 | US$27.9M | 1.0% |
| Oruka Therapeutics, Inc. | 278K | US$26.5M | 0.98% |
| Avalyn Pharma Inc. | 801K | US$26.4M | 0.98% |
| Aveanna Healthcare Holdings Inc. | 3.07M | US$26.3M | 0.97% |
| Bioage Labs, Inc. | 1.03M | US$25.3M | 0.94% |
| Boston Scientific Corporation | 588K | US$25.1M | 0.93% |
| Vera Therapeutics, Inc. | 565K | US$24.2M | 0.90% |
| Repligen Corporation | 177K | US$24.2M | 0.89% |
| Zura Bio Limited | 3.98M | US$23.5M | 0.87% |
| Guardant Health, Inc. | 148K | US$22.2M | 0.82% |
| Evolus, Inc. Common Stock | 3.16M | US$21.9M | 0.81% |
| Natera, Inc. | 79,500 | US$21.6M | 0.80% |
| Orthopediatrics Corp. | 1.1M | US$21.1M | 0.78% |
| Elevance Health, Inc. | 53,960 | US$20.9M | 0.77% |
| Tectonic Therapeutic, Inc. | 597K | US$20.5M | 0.76% |
| Dyne Therapeutics, Inc. | 922K | US$20.5M | 0.76% |
| Argenx Se | 17,707 | US$16.4M | 0.61% |
| Celldex Therapeutics, Inc. | 437K | US$16.2M | 0.60% |
| Ovid Therapeutics Inc. | 5.92M | US$15.9M | 0.59% |
| Mannkind Corporation | 3.46M | US$14.7M | 0.54% |
| X4 Pharmaceuticals, Inc. | 2.92M | US$13.6M | 0.50% |
| Oric Pharmaceuticals, Inc. | 1.21M | US$13.2M | 0.49% |
| Aclaris Therapeutics, Inc. | 2.14M | US$11.3M | 0.42% |
| Seaport Therapeutics, Inc. | 500K | US$10.9M | 0.40% |
| Vor Biopharma Inc. | 573K | US$10.6M | 0.39% |
| Surrozen, Inc. | 391K | US$10.1M | 0.38% |
| Immunic, Inc. | 645K | US$9.91M | 0.37% |
| Helix Acquisition Corp. Iii | 900K | US$9.54M | 0.35% |
| Ionis Pharmaceuticals, Inc. | 117K | US$9.26M | 0.34% |
| Quest Diagnostics Incorporated | 43,200 | US$9.16M | 0.34% |
| Tenax Therapeutics, Inc. | 584K | US$8.5M | 0.31% |
| Kardigan, Inc. | 300K | US$7.16M | 0.26% |
| Amanat Acquisition Corp | 700K | US$7.11M | 0.26% |
| Hemab Therapeutics Holdings, Inc. | 160K | US$5.88M | 0.22% |
| Waters Corporation | 14,040 | US$5.27M | 0.19% |
| Research Alliance Corporation Iii | 400K | US$4.28M | 0.16% |
| Jatt Ii Acquisition Corp | 250K | US$2.84M | 0.11% |
| Pulmonx Corporation | 753K | US$978K | 0.04% |
| Vyne Therapeutics Inc. | 916K | US$596K | 0.02% |
| Cyclerion Therapeutics, Inc. | 157K | US$532K | 0.02% |
| Establishment Labs Holdings Inc. | 0 | US$0 | 0.00% |
| Fulcrum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Grail, Inc. | 0 | US$0 | 0.00% |
| Harrow, Inc. | 0 | US$0 | 0.00% |
| Illumina, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Penumbra, Inc. | 0 | US$0 | 0.00% |
| Praxis Precision Medicines, Inc. | 0 | US$0 | 0.00% |
| Revolution Medicines, Inc. | 0 | US$0 | 0.00% |
| Revvity, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tarsus Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Tg Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Biomarin Pharmaceutical Inc. | 0 | US$0 | 0.00% |
| Celcuity Inc. | 0 | US$0 | 0.00% |
| Centene Corporation | 0 | US$0 | 0.00% |
| Cg Oncology, Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cvs Health Corporation | 0 | US$0 | 0.00% |
| Denali Therapeutics Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |